Interestingly, pre-treatment of diabetic rats with the antioxidant flavonoid troxerutin reduces the diabetes-mediated elevation of both iNOS and COX-2 as well as cytokines production via NFκB inhibition. The gene discussed is PTGS2; the disease is diabetes mellitus.